All Articles

With inflation outpacing typical returns, new data reveals a fractured savings landscape. For today's saver, the greatest risk is not volatility, but inertia.

A Canadian biotech is developing a novel cancer drug. We look beyond the paid promotions to analyze the science, the strategy, and the high-stakes reality.

With a new AI research lab and a $52M Series A, Niural is tackling the hardest problem in AI: building agents for domains where the margin for error is zero.

With traditional banks reducing SME lending, White Oak UK is injecting £1.5B into key industrial sectors, signaling a major shift in business finance.

Hamilton just opened a $390M transit facility. It's not just a garage; it's the critical nerve center for the city's ambitious future of growth and mobility.

Quoin Pharma's new drug name is a key step, but the path to the first-ever treatment for a rare skin disease reveals the complex interplay of innovation and finance.

Former AF Group CEO Elizabeth Haar joins Prescient National's board, signaling a major strategic push to reshape its national footprint and innovate.

NewtekOne just automated a tedious part of getting a business loan. But the real story is its plan to sell this tech to other banks, changing its own game.

With 4K laser projectors at 50% off, Dangbei is betting big that consumers will ditch the TV for a massive, cinematic experience that disappears on command.

A new US policy designates cartels as terrorists, turning Latin American banks into a compliance minefield. The stakes are existential, and the financial network is the front line.

A new report reveals a fractured U.S. housing landscape. While most of the nation sees buyer power grow, tech booms are fueling fierce bidding wars in others.

For 10 years, Charles Schwab has been one of America's most community-minded firms. We dissect how its integrated model is more than charity—it's a strategy.

As quantum threats loom, SEALSQ is set to unveil its U.S. roadmap for hardware-based security, a critical move for national defense and supply chains.

A new partnership puts high-purity recycled plastic in food containers, a breakthrough that helps brands meet tough new laws and growing consumer demand.

As autonomous AI agents multiply, creating chaos and risk, a new class of governance is emerging. A key partnership shows how enterprises can regain control.

A novel drug aims to reverse myelin damage in MS, a feat no current therapy can achieve. But with a recent FDA hold, is Quantum BioPharma's vision a breakthrough or a mirage?

Europastry's acquisition of Highland Baking isn't just a deal; it's a strategic fusion of global scale and artisan quality set to reshape the US market.

Freedom Bank's appointment of Purnachandra Dokku signals a bold new strategy, embedding deep cybersecurity and real estate expertise into its governance.

By launching a Quality of Earnings practice under expert Ryan Irby, GA Group completes its advisory suite, a strategic move to master a complex M&A market.